Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hong-Rui Wang

6PUBLICATIONS
28CO-AUTHORS
Molecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Apr 24, 2023
TMEM25 inhibits monomeric EGFR-mediated STAT3 activation in basal state to suppress triple-negative breast cancer progression.

Jing Bi, Zhihui Wu, Xin Zhang

|Mar 28, 2023
Themis suppresses the effector function of CD8<sup>+</sup> T cells in acute viral infection.

Jian Tang, Xian Jia, Jian Li

|Oct 12, 2022
Targeting EGFR-dependent tumors by disrupting an ARF6-mediated sorting system.

Huiling Guo, Juan Wang, Su Ren

|Feb 15, 2022
Themis is indispensable for IL-2 and IL-15 signaling in T cells.

Yongchao Liu, Yu Cong, Yujia Niu

|Sep 22, 2020
CD36 facilitates fatty acid uptake by dynamic palmitoylation-regulated endocytosis.

Jian-Wei Hao, Juan Wang, Huiling Guo

|Feb 04, 2020
Monoubiquitination of p120-catenin is essential for TGFβ-induced epithelial-mesenchymal transition and tumor metastasis.

Qingang Wu, Gao Li, Chengwen Wen

Pageof 1

Frequent Collaborators

4 joint publications

Xiao Lei Chen

4 joint publications

Guo Fu

3 joint publications

Tong-Jin Zhao

2 joint publications

Bing Xu

2 joint publications

Nicholas R J Gascoigne

2 joint publications

Junchen Dong

2 joint publications

Qian Lai

1 joint publications

Gao Li

1 joint publications

Wei Mo

1 joint publications

Yongchao Liu

Frequent Collaborators

4 joint publications

Xiao Lei Chen

4 joint publications

Guo Fu

3 joint publications

Tong-Jin Zhao

2 joint publications

Bing Xu

Top Related Videos

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.1K
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on : Jun 22, 2016

9.9K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos

Top Related Videos

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-&#946; Signaling and TGF-&#946;-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on : Oct 27, 2020

13.1K
Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
07:17

Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice

Published on : Jun 22, 2016

9.9K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
See more related videos